In addition, the importance of tyrosine phosphorylation of 177 within BCR-ABL in CML pathogenesis has been extensively investigated; in particular, replacing this tyrosine residue with phenylalanine (Y177F) abolishes its transforming activity in vivo [10]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.